Trademarkia Logo

Australia

AU$
Trademark Search
ELIXIRGEN THERAPEUTICS

View On IPO.GOV.AU

ELIXIRGEN THERAPEUTICS
Registered: Registered/protected

Last updated on 14 Mar 2023

Owner Info

Elixirgen Therapeutics, Inc.

855 N. Wolfe St. Suite 624

Baltimore, MD, 21205 UNITED STATES OF AMERICA,

Serial Number

2232618 filed on 1 Dec 2021

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

ELIXIRGEN THERAPEUTICS

Classification Information

Class [005]
Pharmaceutical drugs, Chemical preparations for medicinal purposes, Chemical preparations for pharmaceutical purposes, Preparations of organisms for m Read More

Class [035]
Retail services in relation to pharmaceutical drugs, chemical preparations.

Class [042]
Research and development of vaccines and medicines, Testing of pharmaceuticals, Research in the field of pharmaceuticals.

Mark Details

Serial Number

2232618

Registered On

1 Dec 2021

Renewal On

1 Dec 2031

Mark Type

FIGURATIVE

Legal History

Show more

Status DateAction Taken
14th Mar 2023IP Right Registered correspondence sent
14th Mar 2023IP Right Registration Published
14th Mar 2023Status change to Registered/Protected
5th Jan 2023Application Accepted correspondence sent
5th Jan 2023IP Right has been Examined
5th Jan 2023IP Right Acceptance Published
5th Jan 2023Status change to Accepted
21st Dec 2022Examination Response Received
21st Feb 2022Adverse Report (Examination) correspondence sent
21st Feb 2022IP Right has been Examined